| 产品描述: | Epoprostenol sodium (Prostaglandin I2 (sodium salt)), the synthetic form of the natural prostaglandin derivative prostacyclin (prostaglandin I2), is registered worldwide for the treatment of Pulmonary arterial hypertension (PAH). Epoprostenol sodium is used in pulmonary hypertension and transplantation as a potent inhibitor of platelet aggregation |
| 靶点: |
Human Endogenous Metabolite |
| 参考文献: |
1. Provencher S, et al.Quality of life, safety and efficacy profile of thermostable flolan in pulmonary arterialhypertension. PLoS One. 2015 Mar 20;10(3):e0120657. |
| 溶解性: |
Soluble in H2O |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.671 ml |
13.353 ml |
26.706 ml |
| 5 mM |
0.534 ml |
2.671 ml |
5.341 ml |
| 10 mM |
0.267 ml |
1.335 ml |
2.671 ml |
| 50 mM |
0.053 ml |
0.267 ml |
0.534 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |